"Vitreoretinal medico surgical practice."

During the past decade, West Coast Retina Medical Group, Inc conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 12 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Coast Retina Medical Group, Inc" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Genentech, Inc." with 5 trials sponsored, "Allergan" with 2 trials sponsored, "Jaeb Center for Health Research" with 2 trials sponsored and "National Eye Institute (NEI)" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Coast Retina Medical Group, Inc" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "DataMed Devices Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "West Coast Retina Medical Group, Inc" are "Geographic Atrophy" (7 trials), "Diabetic Macular Edema" (5 trials), "Macular Degeneration" (4 trials), "Macular Edema" (3 trials) and "Neovascular Age-Related Macular Degeneration" (3 trials). Many other conditions were trialed in "West Coast Retina Medical Group, Inc" in a lesser frequency.

Most popular intervention types in "West Coast Retina Medical Group, Inc" are "Drug" (23 trials), "Other" (5 trials), "Procedure" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Faricimab" (3 trials) and "Galegenimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "West Coast Retina Medical Group, Inc" are 27 trials for "All" genders.

Currently, there are NaN active trials in "West Coast Retina Medical Group, Inc". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in West Coast Retina Medical Group, Inc, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in West Coast Retina Medical Group, Inc, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".